Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrasound-guided saphenous nerve block approaches for sub-knee surgery
ACTRN12614000057684Phase 4Not yet recruiting
- Sponsor
- Levent Sahin
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of levobupivacaine and lidocaine (2 arms), sponsored by Levent Sahin. Primary endpoint: Duration of anaesthetic effect. Planned start Jan 2014; status: not yet recruiting.
02
Drugs
levobupivacainelidocaine
Beyond the preview
Go deeper on ACTRN12614000057684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000057684.